Chunjian Gu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chunjian Gu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Hongyang Li
Department of Orthopedics, First Hospital of China Medical University, Shenyang, China
1 shared publication - Jing Hang
Department of Obstetrics and Gynecology, Center for Reproductive Medicine, State Key Laboratory of Female Fertility Promotion, Peking University Third Hospital, Beijing, China
1 shared publication - Jinna Dai
National Clinical Research Center for Medical Auxiliary Technology ( Laboratory Medicine), Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang 110001, China
1 shared publication - Jinpeng Wang
Department of Orthopedics First Hospital of China Medical University Shenyang China
1 shared publication - Lianfeng Shan
Department of Intelligent Computing, School of Intelligent Medicine, China Medical University, Shenyang, China
1 shared publication - Lin Tao
Department of Orthopedics First Hospital of China Medical University Shenyang China
1 shared publication
Latest Publications
- Open Access
- 18 February 2025
- Published by British Editorial Society of Bone & Joint Surgery in Bone & Joint Research
- Vol. 14 (2) , 111-123
Development and validation of a novel prediction model for osteoporosis
Aims: We aimed to develop and validate a novel prediction model for osteoporosis based on serotonin, fat-soluble vitamins, and bone turnover markers to improve prediction accuracy of osteoporosis.Methods: Postmenopausal women aged 55 to 65 years were recruited and divided into three groups based on DXA (normal, osteopenia, and osteoporosis). A total of 109 participants were included in this study and split into healthy (39/109, 35.8%), osteopenia (35/109, 32.1%), and osteoporosis groups (35/109, 32.1%). Serum concentrations of serotonin, fat-soluble vitamins, and bone turnover markers of participants were measured. Stepwise discriminant analysis was performed to identify efficient predictors for osteoporosis. The prediction model was developed based on Bayes and Fisher’s discriminant functions, and validated via leave-one-out cross-validation. Normal and empirical volume under the receiver operating characteristic (ROC) surface (VUS) tests were used to evaluate predictive effects of variables in the prediction model.Results: Significant variables including oestrogen (E2), total procollagen type 1 amino-terminal propeptide (TP1NP), parathyroid hormone (PTH), BMI, vitamin K, serotonin, osteocalcin (OSTEOC), vitamin A, and vitamin D3 were used for the development of the prediction model. The training accuracy for normal, osteopenia, and osteoporosis is 74.4% (29/39), 80.0% (28/35), and 85.7% (30/35), respectively, while the total training accuracy is 79.8% (87/109). The internal validation showed excellent performance with 72.5% testing accuracy (72/109). Among these variables, serotonin and vitamin K exert important roles in the prediction of osteoporosis.Conclusion: We successfully developed and validated a novel prediction model for osteoporosis based on serum concentrations of serotonin, fat-soluble vitamins, and bone turnover markers. In addition, interactive communication between serotonin and fat-soluble vitamins was observed to be critical for bone health in this study.Cite this article: Bone Joint Res 2025;14(2):111–123.
- 18 February 2025
- Published by British Editorial Society of Bone & Joint Surgery in Bone & Joint Research
- Vol. 14 (2) , 111-123
Open AccessDevelopment and validation of a novel prediction model for osteoporosis
Aims: We aimed to develop and validate a novel prediction model for osteoporosis based on serotonin, fat-soluble vitamins, and bone turnover markers to improve prediction accuracy of osteoporosis.Methods: Postmenopausal women aged 55 to 65 years were recruited and divided into three groups based on DXA (normal, osteopenia, and osteoporosis). A total of 109 participants were included in this study and split into healthy (39/109, 35.8%), osteopenia (35/109, 32.1%), and osteoporosis groups (35/109, 32.1%). Serum concentrations of serotonin, fat-soluble vitamins, and bone turnover markers of participants were measured. Stepwise discriminant analysis was performed to identify efficient predictors for osteoporosis. The prediction model was developed based on Bayes and Fisher’s discriminant functions, and validated via leave-one-out cross-validation. Normal and empirical volume under the receiver operating characteristic (ROC) surface (VUS) tests were used to evaluate predictive effects of variables in the prediction model.Results: Significant variables including oestrogen (E2), total procollagen type 1 amino-terminal propeptide (TP1NP), parathyroid hormone (PTH), BMI, vitamin K, serotonin, osteocalcin (OSTEOC), vitamin A, and vitamin D3 were used for the development of the prediction model. The training accuracy for normal, osteopenia, and osteoporosis is 74.4% (29/39), 80.0% (28/35), and 85.7% (30/35), respectively, while the total training accuracy is 79.8% (87/109). The internal validation showed excellent performance with 72.5% testing accuracy (72/109). Among these variables, serotonin and vitamin K exert important roles in the prediction of osteoporosis.Conclusion: We successfully developed and validated a novel prediction model for osteoporosis based on serum concentrations of serotonin, fat-soluble vitamins, and bone turnover markers. In addition, interactive communication between serotonin and fat-soluble vitamins was observed to be critical for bone health in this study.Cite this article: Bone Joint Res 2025;14(2):111–123.